| CRC | Colorectal cancer |
| FAP | Familial adenomatous polyposis; |
| HMPS | Hereditary mixed polyposis syndrome |
| HNPCC | Hereditary non-polyposis colorectal cancer, Lynch syndrome; associated polyposis |
| MAP | MUTYH-associated polyposis |
| MUTYH | base excision repair gene; biallelic mutations predispose to colorectal cancer. |
| 5-FU | 5-fluorouracil |
| CEA | carcinoembryonic antigen |
| CT | computed tomography |
| MRI | magnetic resonance imaging |
| FOBT | fecal occult blood testing |
| FIT | fecal immunochemical testing |
| sDNA-FIT | stool DNA testing |
| miRNA | MicroRNA |
| mSEPT9 | methylated SEPT9 |
| CTCs | circulating tumor cells |
| ctDNA | circulating tumor DNA |
| CA 19-9 | Carbohydrate antigen 19-9 |
| TPS | Tissue polypeptide-specific antigen |
| TAG-72 | Tumor-associated glycoprotein 72 |
| CA 72-4 | Carbohydrate antigen 72-4 |
| CIN | chromosomal instability |
| MSI | microsatellite instability |
| PTEN | Phosphatase and tensin homolog |
| CIMP | CpG island methylator phenotype |